ShanXi C&Y Pharmaceutical Group Co.,LTD. (SHE:300254)
China flag China · Delayed Price · Currency is CNY
12.28
+0.10 (0.82%)
Feb 27, 2026, 3:04 PM CST

SHE:300254 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
3,1452,1732,3271,6361,9811,571
Market Cap Growth
53.52%-6.62%42.24%-17.43%26.13%-7.02%
Enterprise Value
3,8252,3522,5791,7732,2481,769
Last Close Price
12.288.759.636.778.696.89
PE Ratio
147.1551.5092.35---
Forward PE
-47.4847.4847.4847.4847.48
PS Ratio
3.702.572.911.972.131.85
PB Ratio
5.453.632.992.242.661.80
P/TBV Ratio
--25.9332.4868.4921.65
P/FCF Ratio
48.99111.77596.9134.0133.02-
P/OCF Ratio
37.7630.6361.5321.8520.44-
EV/Sales Ratio
4.502.783.232.142.422.09
EV/EBITDA Ratio
29.0420.6633.2051.1763.24-
EV/EBIT Ratio
50.7537.35102.75---
EV/FCF Ratio
59.58120.98661.6236.8737.47-
Debt / Equity Ratio
0.910.520.290.400.310.35
Debt / EBITDA Ratio
4.002.582.717.025.92-
Debt / FCF Ratio
8.2016.0358.036.013.83-
Net Debt / Equity Ratio
0.690.270.120.030.160.14
Net Debt / EBITDA Ratio
3.181.421.210.723.44-0.88
Net Debt / FCF Ratio
6.198.3424.170.522.04-2.24
Asset Turnover
0.550.570.530.530.560.47
Inventory Turnover
2.222.232.322.372.512.09
Quick Ratio
0.620.600.630.630.630.87
Current Ratio
0.920.880.960.850.941.18
Return on Equity (ROE)
7.85%10.86%6.46%-13.28%-9.22%-31.08%
Return on Assets (ROA)
3.06%2.64%1.04%-0.95%-1.06%-6.88%
Return on Invested Capital (ROIC)
5.32%7.15%2.72%-2.92%-3.03%-18.65%
Return on Capital Employed (ROCE)
7.70%6.40%2.50%-2.40%-2.50%-15.10%
Earnings Yield
0.65%1.94%1.08%-7.25%-4.62%-16.70%
FCF Yield
2.04%0.90%0.17%2.94%3.03%-3.33%
Payout Ratio
90.75%29.20%52.84%---
Buyback Yield / Dilution
-0.95%-0.20%-1.89%-4.00%-6.92%-2.25%
Total Shareholder Return
-0.95%-0.20%-1.89%-4.00%-6.92%-2.25%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.